LABCORP HOLDINGS INC. 8-K

What Happened

• On January 28, 2026, Labcorp Holdings (through Labcorp Receivables LLC and acknowledged by Laboratory Corporation of America Holdings) entered into a Second Amendment to its Receivables Purchase Agreement with PNC Bank, extending the scheduled termination date to January 26, 2029. The amendment also adds a committed $125 million accordion and removes a previously applied 0.10% SOFR adjustment to the capital-accruing yield.

Key Details

• Effective date: January 28, 2026 (amendment executed).
• Termination extended to January 26, 2029.
• $125 million committed accordion facility allows increasing the facility from $700 million to up to $825 million on or before May 29, 2026.
• The 0.10% SOFR adjustment previously added to capital-accruing yield at daily 1M SOFR or term SOFR was removed.
• Labcorp Receivables LLC is a separate legal entity: its assets secure its own creditors first; only collections in excess of amounts due to Labcorp Receivables’ purchasers and creditors may be remitted to the parent company.

Why It Matters

• The amendment increases Labcorp’s short-term funding flexibility by raising the maximum receivables facility and extending its maturity, which can support working capital or liquidity needs.
• Removing the 0.10% SOFR adjustment may modestly lower financing cost under the facility when SOFR-based rates apply.
• Because Labcorp Receivables is a separate legal entity with creditor priority over its assets, these receivables remain ring-fenced for that vehicle’s creditors; any benefit to the parent depends on excess collections after the vehicle’s obligations are satisfied.